𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hormonal therapy for postmenopausal breast cancer: the science of sequencing

✍ Scribed by William R. Miller; John M. S. Bartlett; Peter Canney; Mark Verrill


Publisher
Springer US
Year
2006
Tongue
English
Weight
287 KB
Volume
103
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Hormonal therapy of breast cancer
✍ Peter F Lebowitz; JoAnne Zujewski πŸ“‚ Article πŸ“… 2003 πŸ› Elsevier Science 🌐 English βš– 440 KB
Postmenopausal hormone therapy and breas
✍ Sulggi Lee; Laurence Kolonel; Lynne Wilkens; Peggy Wan; Brian Henderson; Malcolm πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 95 KB πŸ‘ 2 views

## Abstract Epidemiological studies indicate that menopausal estrogen‐progestin therapy (EPT) use is associated with an increase in breast cancer risk. Further data are needed on whether this association varies by specific prognostic factors and ethnicity. We conducted a cohort study among 55,371 A

Obesity, hormone therapy, estrogen metab
✍ Francesmary Modugno; Kevin E. Kip; Barbara Cochrane; Lewis Kuller; Thomas L. Klu πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 302 KB πŸ‘ 2 views

## Abstract Hormone therapy (HT) and body mass index (BMI) have been associated with postmenopausal breast cancer. Because estrogen metabolism may affect breast cancer risk and can be altered by weight and HT, it might play a role in the HT–BMI–breast cancer associations. We undertook a nested case